The DOI matches its Crossref record; 670 of the 670 references it cites were found in a registry or an index.
Harnessing innate immune pathways for therapeutic advancement in cancer
Open accessAbstract
The innate immune pathway is receiving increasing attention in cancer therapy. This pathway is ubiquitous across various cell types, not only in innate immune cells but also in adaptive immune cells, tumor cells, and stromal cells. Agonists targeting the innate immune pathway have shown profound changes in the tumor microenvironment (TME) and improved tumor prognosis in preclinical studies. However, to date, the clinical success of drugs targeting the innate immune pathway remains limited. Interestingly, recent studies have shown that activation of the innate immune pathway can paradoxically promote tumor progression. The uncertainty surrounding the therapeutic effectiveness of targeted drugs for the innate immune pathway is a critical issue that needs immediate investigation. In this review, we observe that the role of the innate immune pathway demonstrates heterogeneity, linked to the tumor development stage, pathway status, and specific cell types. We propose that within the TME, the innate immune pathway exhibits multidimensional diversity. This diversity is fundamentally rooted in cellular heterogeneity and is manifested as a variety of signaling networks. The pro-tumor effect of innate immune pathway activation essentially reflects the suppression of classical pathways and the activation of potential pro-tumor alternative pathways. Refining our understanding of the tumor’s innate immune pathway network and employing appropriate targeting strategies can enhance our ability to harness the anti-tumor potential of the innate immune pathway and ultimately bridge the gap from preclinical to clinical application.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Items 201–400 of 670
cGAS-STING pathway in cancer biotherapy
Wang, Y., Luo, J., Alu, A., Han, X., Wei, Y., & Wei, X. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01247-w · Cited by 399
Epithelial Toll-like receptors and their role in gut homeostasis and disease
Burgueño, J. F., & Abreu, M. T. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0261-4 · Cited by 395
CTLA-4 blockade drives loss of Treg stability in glycolysis-low tumours
Zappasodi, R., Serganova, I., Cohen, I. J., Maeda, M., Shindo, M., Senbabaoglu, Y., Watson, M. J., Leftin, A., Maniyar, R., Verma, S., et al. (2021) · Nature · doi:10.1038/s41586-021-03326-4 · Cited by 393
A2AR Adenosine Signaling Suppresses Natural Killer Cell Maturation in the Tumor Microenvironment
Young, A., Ngiow, S. F., Gao, Y., Patch, A.-M., Barkauskas, D. S., Messaoudene, M., Lin, G., Coudert, J. D., Stannard, K. A., Zitvogel, L., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-2826 · Cited by 391
Combinatorial Strategies for the Induction of Immunogenic Cell Death
Bezu, L., Gomes-de-Silva, L. C., Dewitte, H., Breckpot, K., Fucikova, J., Spisek, R., Galluzzi, L., Kepp, O., & Kroemer, G. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00187 · Cited by 390
5′-triphosphate-siRNA: turning gene silencing and Rig-I activation against melanoma
Poeck, H., Besch, R., Maihoefer, C., Renn, M., Tormo, D., Morskaya, S. S., Kirschnek, S., Gaffal, E., Landsberg, J., Hellmuth, J., et al. (2008) · Nature Medicine · doi:10.1038/nm.1887 · Cited by 387
Toll-Like Receptor Ligands Directly Promote Activated CD4+ T Cell Survival
Gelman, A. E., Zhang, J., Choi, Y., & Turka, L. A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.10.6065 · Cited by 386
NLRC5: a key regulator of MHC class I-dependent immune responses
Kobayashi, K. S., & van den Elsen, P. J. (2012) · Nature Reviews Immunology · doi:10.1038/nri3339 · Cited by 384
Recurrent Loss of STING Signaling in Melanoma Correlates with Susceptibility to Viral Oncolysis
Xia, T., Konno, H., & Barber, G. N. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-1404 · Cited by 383
SLC19A1 transports immunoreactive cyclic dinucleotides.
Luteijn, R. D., Zaver, S. A., Gowen, B. G., Wyman, S. K., Garelis, N. E., Onia, L., McWhirter, S. M., Katibah, G. E., Corn, J. E., Woodward, J. J., et al. (2019) · Nature · doi:10.1038/s41586-019-1553-0 · Cited by 379
TLR signaling by tumor and immune cells: a double-edged sword
Huang, B., Zhao, J., Unkeless, J. C., Feng, Z. H., & Xiong, H. (2008) · Oncogene · doi:10.1038/sj.onc.1210904 · Cited by 377
Type I interferon response and innate immune sensing of cancer
Fuertes, M. B., Woo, S.-R., Burnett, B., Fu, Y.-X., & Gajewski, T. F. (2013) · Trends in Immunology · doi:10.1016/j.it.2012.10.004 · Cited by 375
Transcriptional regulation of myeloid-derived suppressor cells
Condamine, T., Mastio, J., & Gabrilovich, D. I. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.4ri0515-204r · Cited by 372
TIM-3 restrains anti-tumour immunity by regulating inflammasome activation
Dixon, K. O., Tabaka, M., Schramm, M. A., Xiao, S., Tang, R., Dionne, D., Anderson, A. C., Rozenblatt-Rosen, O., Regev, A., & Kuchroo, V. K. (2021) · Nature · doi:10.1038/s41586-021-03626-9 · Cited by 372
cGAS–STING drives the IL-6-dependent survival of chromosomally instable cancers
Hong, C., Schubert, M., Tijhuis, A. E., Requesens, M., Roorda, M., van den Brink, A., Ruiz, L. A., Bakker, P. L., van der Sluis, T., Pieters, W., et al. (2022) · Nature · doi:10.1038/s41586-022-04847-2 · Cited by 371
Hou, B., Reizis, B., & DeFranco, A. L. (2008) · Immunity · doi:10.1016/j.immuni.2008.05.016 · Cited by 363
Raychaudhuri, B., Rayman, P., Ireland, J., Ko, J., Rini, B., Borden, E. C., Garcia, J., Vogelbaum, M. A., & Finke, J. (2011) · Neuro-Oncology · doi:10.1093/neuonc/nor042 · Cited by 359
Metabolic requirements for neutrophil extracellular traps formation
Rodríguez‐Espinosa, O., Rojas‐Espinosa, O., Moreno‐Altamirano, M. M. B., López‐Villegas, E. O., & Sánchez‐García, F. J. (2015) · Immunology · doi:10.1111/imm.12437 · Cited by 354
Rice, C. M., Davies, L. C., Subleski, J. J., Maio, N., Gonzalez-Cotto, M., Andrews, C., Patel, N. L., Palmieri, E. M., Weiss, J. M., Lee, J.-M., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07505-2 · Cited by 353
Viganò, E., Diamond, C. E., Spreafico, R., Balachander, A., Sobota, R. M., & Mortellaro, A. (2015) · Nature Communications · doi:10.1038/ncomms9761 · Cited by 352
Youn, J.-I., Kumar, V., Collazo, M., Nefedova, Y., Condamine, T., Cheng, P., Villagra, A., Antonia, S., McCaffrey, J. C., Fishman, M., et al. (2013) · Nature Immunology · doi:10.1038/ni.2526 · Cited by 350
Nuclear hnRNPA2B1 initiates and amplifies the innate immune response to DNA viruses
Wang, L., Wen, M., & Cao, X. (2019) · Science · doi:10.1126/science.aav0758 · Cited by 348
Mutant p53 suppresses innate immune signaling to promote tumorigenesis
Ghosh, M., Saha, S., Bettke, J., Nagar, R., Parrales, A., Iwakuma, T., van der Velden, A. W. M., & Martinez, L. A. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.01.003 · Cited by 348
STING-induced regulatory B cells compromise NK function in cancer immunity
Li, S., Mirlekar, B., Johnson, B. M., Brickey, W. J., Wrobel, J. A., Yang, N., Song, D., Entwistle, S., Tan, X., Deng, M., et al. (2022) · Nature · doi:10.1038/s41586-022-05254-3 · Cited by 347
Al-Khami, A. A., Zheng, L., Del Valle, L., Hossain, F., Wyczechowska, D., Zabaleta, J., Sanchez, M. D., Dean, M. J., Rodriguez, P. C., & Ochoa, A. C. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1344804 · Cited by 346
Dupaul-Chicoine, J., Arabzadeh, A., Dagenais, M., Douglas, T., Champagne, C., Morizot, A., Rodrigue-Gervais, I. G., Breton, V., Colpitts, S. L., Beauchemin, N., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.08.013 · Cited by 342
He, W., Liu, Q., Wang, L., Chen, W., Li, N., & Cao, X. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2007.01.022 · Cited by 340
Ribas, A., Medina, T., Kummar, S., Amin, A., Kalbasi, A., Drabick, J. J., Barve, M., Daniels, G. A., Wong, D. J., Schmidt, E. V., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-0280 · Cited by 337
Biopolymers codelivering engineered T cells and STING agonists can eliminate heterogeneous tumors
Smith, T. T., Moffett, H. F., Stephan, S. B., Opel, C. F., Dumigan, A. G., Jiang, X., Pillarisetty, V. G., Pillai, S. P. S., Wittrup, K. D., & Stephan, M. T. (2017) · Journal of Clinical Investigation · doi:10.1172/jci87624 · Cited by 336
Inosine is an alternative carbon source for CD8+-T-cell function under glucose restriction
Wang, T., Gnanaprakasam, J. N. R., Chen, X., Kang, S., Xu, X., Sun, H., Liu, L., Rodgers, H., Miller, E., Cassel, T. A., et al. (2020) · Nature Metabolism · doi:10.1038/s42255-020-0219-4 · Cited by 331
Lactate metabolism is associated with mammalian mitochondria
Chen, Y.-J., Mahieu, N. G., Huang, X., Singh, M., Crawford, P. A., Johnson, S. L., Gross, R. W., Schaefer, J., & Patti, G. J. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2172 · Cited by 326
Metabolic changes in tumor cells and tumor-associated macrophages: A mutual relationship
Netea-Maier, R. T., Smit, J. W. A., & Netea, M. G. (2018) · Cancer Letters · doi:10.1016/j.canlet.2017.10.037 · Cited by 326
STING Promotes the Growth of Tumors Characterized by Low Antigenicity via IDO Activation
Lemos, H., Mohamed, E., Huang, L., Ou, R., Pacholczyk, G., Arbab, A. S., Munn, D., & Mellor, A. L. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-1456 · Cited by 325
Si, W., Liang, H., Bugno, J., Xu, Q., Ding, X., Yang, K., Fu, Y., Weichselbaum, R. R., Zhao, X., & Wang, L. (2022) · Gut · doi:10.1136/gutjnl-2020-323426 · Cited by 321
Differentiation and Regulation of TH Cells: A Balancing Act for Cancer Immunotherapy
Basu, A., Ramamoorthi, G., Albert, G., Gallen, C., Beyer, A., Snyder, C., Koski, G., Disis, M. L., Czerniecki, B. J., & Kodumudi, K. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.669474 · Cited by 321
Agonist-Mediated Activation of STING Induces Apoptosis in Malignant B Cells
Tang, C.-H. A., Zundell, J. A., Ranatunga, S., Lin, C., Nefedova, Y., Del Valle, J. R., & Hu, C.-C. A. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-1885 · Cited by 319
Xu, M. M., Pu, Y., Han, D., Shi, Y., Cao, X., Liang, H., Chen, X., Li, X.-D., Deng, L., Chen, Z. J., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.07.016 · Cited by 315
T-cell Dysfunction in Glioblastoma: Applying a New Framework
Woroniecka, K. I., Rhodin, K. E., Chongsathidkiet, P., Keith, K. A., & Fecci, P. E. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-0047 · Cited by 315
Metastasis and Immune Evasion from Extracellular cGAMP Hydrolysis
Li, J., Duran, M. A., Dhanota, N., Chatila, W. K., Bettigole, S. E., Kwon, J., Sriram, R. K., Humphries, M. P., Salto-Tellez, M., James, J. A., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0387 · Cited by 312
Rutkowski, M. R., Stephen, T. L., Svoronos, N., Allegrezza, M. J., Tesone, A. J., Perales-Puchalt, A., Brencicova, E., Escovar-Fadul, X., Nguyen, J. M., Cadungog, M. G., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2014.11.009 · Cited by 311
TLR7/8-Mediated Activation of Human NK Cells Results in Accessory Cell-Dependent IFN-γ Production
Hart, O. M., Athie-Morales, V., O’Connor, G. M., & Gardiner, C. M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.3.1636 · Cited by 310
Type I interferon-mediated tumor immunity and its role in immunotherapy
Yu, R., Zhu, B., & Chen, D. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04219-z · Cited by 309
The Role of TLRs in Anti-cancer Immunity and Tumor Rejection
Urban-Wojciuk, Z., Khan, M. M., Oyler, B. L., Fåhraeus, R., Marek-Trzonkowska, N., Nita-Lazar, A., Hupp, T. R., & Goodlett, D. R. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02388 · Cited by 307
Non-cell-autonomous cancer progression from chromosomal instability
Li, J., Hubisz, M. J., Earlie, E. M., Duran, M. A., Hong, C., Varela, A. A., Lettera, E., Deyell, M., Tavora, B., Havel, J. J., et al. (2023) · Nature · doi:10.1038/s41586-023-06464-z · Cited by 307
Metabolic flexibility determines human NK cell functional fate in the tumor microenvironment
Poznanski, S. M., Singh, K., Ritchie, T. M., Aguiar, J. A., Fan, I. Y., Portillo, A. L., Rojas, E. A., Vahedi, F., El-Sayes, A., Xing, S., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.03.023 · Cited by 306
Li, W., Lu, L., Lu, J., Wang, X., Yang, C., Jin, J., Wu, L., Hong, X., Li, F., Cao, D., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aay9013 · Cited by 305
Tumor infiltrating immune cells in gliomas and meningiomas
Domingues, P., González-Tablas, M., Otero, Á., Pascual, D., Miranda, D., Ruiz, L., Sousa, P., Ciudad, J., Gonçalves, J. M., Lopes, M. C., et al. (2016) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.07.019 · Cited by 302
Herr, H. W., Schwalb, D. M., Zhang, Z. F., Sogani, P. C., Fair, W. R., Whitmore, W. F., & Oettgen, H. F. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.6.1404 · Cited by 300
Reynolds, J. M., Pappu, B. P., Peng, J., Martinez, G. J., Zhang, Y., Chung, Y., Ma, L., Yang, X. O., Nurieva, R. I., Tian, Q., et al. (2010) · Immunity · doi:10.1016/j.immuni.2010.04.010 · Cited by 299
Treatment of genital warts with an immune-response modifier (imiquimod)
Beutner, K. R., Spruance, S. L., Hougham, A. J., Fox, T. L., Owens, M. L., & Douglas, J. M. (1998) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(98)70243-9 · Cited by 299
Intrinsic antiproliferative activity of the innate sensor STING in T lymphocytes
Cerboni, S., Jeremiah, N., Gentili, M., Gehrmann, U., Conrad, C., Stolzenberg, M.-C., Picard, C., Neven, B., Fischer, A., Amigorena, S., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20161674 · Cited by 299
Macrophages of distinct origins contribute to tumor development in the lung
Loyher, P.-L., Hamon, P., Laviron, M., Meghraoui-Kheddar, A., Goncalves, E., Deng, Z., Torstensson, S., Bercovici, N., Baudesson de Chanville, C., Combadière, B., et al. (2018) · Journal of Experimental Medicine · doi:10.1084/jem.20180534 · Cited by 298
Lei, Y., Wen, H., Yu, Y., Taxman, D. J., Zhang, L., Widman, D. G., Swanson, K. V., Wen, K.-W., Damania, B., Moore, C. B., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.03.025 · Cited by 295
Liu, M., O’Connor, R. S., Trefely, S., Graham, K., Snyder, N. W., & Beatty, G. L. (2019) · Nature Immunology · doi:10.1038/s41590-018-0292-y · Cited by 294
The immune system and response to HER2-targeted treatment in breast cancer
Bianchini, G., & Gianni, L. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70477-7 · Cited by 286
Sato-Kaneko, F., Yao, S., Ahmadi, A., Zhang, S. S., Hosoya, T., Kaneda, M. M., Varner, J. A., Pu, M., Messer, K. S., Guiducci, C., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.93397 · Cited by 280
The IL-2 cytokine family in cancer immunotherapy
Sim, G. C., & Radvanyi, L. (2014) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.07.018 · Cited by 278
NLRC5/MHC class I transactivator is a target for immune evasion in cancer
Yoshihama, S., Roszik, J., Downs, I., Meissner, T. B., Vijayan, S., Chapuy, B., Sidiq, T., Shipp, M. A., Lizee, G. A., & Kobayashi, K. S. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1602069113 · Cited by 276
Wu, S., Zhang, Q., Zhang, F., Meng, F., Liu, S., Zhou, R., Wu, Q., Li, X., Shen, L., Huang, J., et al. (2019) · Nature Cell Biology · doi:10.1038/s41556-019-0352-z · Cited by 275
Konno, H., Yamauchi, S., Berglund, A., Putney, R. M., Mulé, J. J., & Barber, G. N. (2018) · Oncogene · doi:10.1038/s41388-017-0120-0 · Cited by 274
Antitumour dendritic cell vaccination in a priming and boosting approach
Harari, A., Graciotti, M., Bassani-Sternberg, M., & Kandalaft, L. E. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0074-8 · Cited by 271
Liu, Y., Yan, W., Tohme, S., Chen, M., Fu, Y., Tian, D., Lotze, M., Tang, D., & Tsung, A. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.02.009 · Cited by 267
Non-canonical NF-κB Antagonizes STING Sensor-Mediated DNA Sensing in Radiotherapy
Hou, Y., Liang, H., Rao, E., Zheng, W., Huang, X., Deng, L., Zhang, Y., Yu, X., Xu, M., Mauceri, H., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.07.008 · Cited by 265
Yuan, R., Zhao, W., Wang, Q.-Q., He, J., Han, S., Gao, H., Feng, Y., & Yang, S. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105748 · Cited by 265
Cytoprotective roles for autophagy
Moreau, K., Luo, S., & Rubinsztein, D. C. (2010) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.12.002 · Cited by 264
T Cell Activation and the Cytoskeleton
Acuto, O., & Cantrell, D. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.165 · Cited by 264
The LPS-inducible lncRNA Mirt2 is a negative regulator of inflammation
Du, M., Yuan, L., Tan, X., Huang, D., Wang, X., Zheng, Z., Mao, X., Li, X., Yang, L., Huang, K., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-02229-1 · Cited by 263
Wang, Q., Bergholz, J. S., Ding, L., Lin, Z., Kabraji, S. K., Hughes, M. E., He, X., Xie, S., Jiang, T., Wang, W., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30568-1 · Cited by 258
Nakamura, T., Sato, T., Endo, R., Sasaki, S., Takahashi, N., Sato, Y., Hyodo, M., Hayakawa, Y., & Harashima, H. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-002852 · Cited by 257
STING activation in cancer immunotherapy
Su, T., Zhang, Y., Valerie, K., Wang, X.-Y., Lin, S., & Zhu, G. (2019) · Theranostics · doi:10.7150/thno.37574 · Cited by 256
Cancer Cell Secretion of the DAMP Protein HMGB1 Supports Progression in Malignant Mesothelioma
Jube, S., Rivera, Z. S., Bianchi, M. E., Powers, A., Wang, E., Pagano, I., Pass, H. I., Gaudino, G., Carbone, M., & Yang, H. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3481 · Cited by 255
Self-citationEffector, Memory, and Dysfunctional CD8+T Cell Fates in the Antitumor Immune Response
Reiser, J., & Banerjee, A. (2016) · Journal of Immunology Research · doi:10.1155/2016/8941260 · Cited by 255
Liu, Y., Crowe, W. N., Wang, L., Lu, Y., Petty, W. J., Habib, A. A., & Zhao, D. (2019) · Nature Communications · doi:10.1038/s41467-019-13094-5 · Cited by 254
TH2-Polarized CD4+ T Cells and Macrophages Limit Efficacy of Radiotherapy
Shiao, S. L., Ruffell, B., DeNardo, D. G., Faddegon, B. A., Park, C. C., & Coussens, L. M. (2015) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0232 · Cited by 253
Theivanthiran, B., Evans, K. S., DeVito, N. C., Plebanek, M., Sturdivant, M., Wachsmuth, L. P., Salama, A. K. S., Kang, Y., Hsu, D., Balko, J. M., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci133055 · Cited by 248
Meric-Bernstam, F., Sweis, R. F., Kasper, S., Hamid, O., Bhatia, S., Dummer, R., Stradella, A., Long, G. V., Spreafico, A., Shimizu, T., et al. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-2235 · Cited by 248
STING inhibits the reactivation of dormant metastasis in lung adenocarcinoma
Hu, J., Sánchez-Rivera, F. J., Wang, Z., Johnson, G. N., Ho, Y.-J., Ganesh, K., Umeda, S., Gan, S., Mujal, A. M., Delconte, R. B., et al. (2023) · Nature · doi:10.1038/s41586-023-05880-5 · Cited by 247
Li, L., Liu, X., Sanders, K. L., Edwards, J. L., Ye, J., Si, F., Gao, A., Huang, L., Hsueh, E. C., Ford, D. A., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2018.09.020 · Cited by 245
NLRP3 signaling drives macrophage-induced adaptive immune suppression in pancreatic carcinoma
Daley, D., Mani, V. R., Mohan, N., Akkad, N., Pandian, G. S. D. B., Savadkar, S., Lee, K. B., Torres-Hernandez, A., Aykut, B., Diskin, B., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20161707 · Cited by 244
von Roemeling, C. A., Wang, Y., Qie, Y., Yuan, H., Zhao, H., Liu, X., Yang, Z., Yang, M., Deng, W., Bruno, K. A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15129-8 · Cited by 242
Ma, Z., Li, X., Mao, Y., Wei, C., Huang, Z., Li, G., Yin, J., Liang, X., & Liu, Z. (2022) · Cancer Cell · doi:10.1016/j.ccell.2022.11.005 · Cited by 242
Self-citationObesity-associated NLRC4 inflammasome activation drives breast cancer progression
Kolb, R., Phan, L., Borcherding, N., Liu, Y., Yuan, F., Janowski, A. M., Xie, Q., Markan, K. R., Li, W., Potthoff, M. J., et al. (2016) · Nature Communications · doi:10.1038/ncomms13007 · Cited by 239
Wang, E. L., Qian, Z. R., Nakasono, M., Tanahashi, T., Yoshimoto, K., Bando, Y., Kudo, E., Shimada, M., & Sano, T. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605558 · Cited by 238
Plasticity of human Th17 cells and iTregs is orchestrated by different subsets of myeloid cells
Hoechst, B., Gamrekelashvili, J., Manns, M. P., Greten, T. F., & Korangy, F. (2011) · Blood · doi:10.1182/blood-2010-11-317321 · Cited by 238
Echizen, K., Hirose, O., Maeda, Y., & Oshima, M. (2016) · Cancer Science · doi:10.1111/cas.12901 · Cited by 238
IL-2 Is Not Required for the Initiation of CD8 T Cell Cycling but Sustains Expansion
D’Souza, W. N., & Lefrançois, L. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.11.5727 · Cited by 237
Cutting Edge: TLR Signaling Licenses IRAK1 for Rapid Activation of the NLRP3 Inflammasome
Fernandes-Alnemri, T., Kang, S., Anderson, C., Sagara, J., Fitzgerald, K. A., & Alnemri, E. S. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301681 · Cited by 237
Saitoh, T., Satoh, T., Yamamoto, N., Uematsu, S., Takeuchi, O., Kawai, T., & Akira, S. (2011) · Immunity · doi:10.1016/j.immuni.2011.03.010 · Cited by 234
NONO Detects the Nuclear HIV Capsid to Promote cGAS-Mediated Innate Immune Activation
Lahaye, X., Gentili, M., Silvin, A., Conrad, C., Picard, L., Jouve, M., Zueva, E., Maurin, M., Nadalin, F., Knott, G. J., et al. (2018) · Cell · doi:10.1016/j.cell.2018.08.062 · Cited by 233
The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancer
Michaelis, K. A., Norgard, M. A., Zhu, X., Levasseur, P. R., Sivagnanam, S., Liudahl, S. M., Burfeind, K. G., Olson, B., Pelz, K. R., Angeles Ramos, D. M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12657-w · Cited by 230
Rook, A. H., Gelfand, J. M., Wysocka, M., Troxel, A. B., Benoit, B., Surber, C., Elenitsas, R., Buchanan, M. A., Leahy, D. S., Watanabe, R., et al. (2015) · Blood · doi:10.1182/blood-2015-02-630335 · Cited by 224
MEK inhibition overcomes chemoimmunotherapy resistance by inducing CXCL10 in cancer cells
Limagne, E., Nuttin, L., Thibaudin, M., Jacquin, E., Aucagne, R., Bon, M., Revy, S., Barnestein, R., Ballot, E., Truntzer, C., et al. (2022) · Cancer Cell · doi:10.1016/j.ccell.2021.12.009 · Cited by 224
Merrell, M. A., Ilvesaro, J. M., Lehtonen, N., Sorsa, T., Gehrs, B., Rosenthal, E., Chen, D., Shackley, B., Harris, K. W., & Selander, K. S. (2006) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0007 · Cited by 223
Hu, G., Gong, A.-Y., Wang, Y., Ma, S., Chen, X., Chen, J., Su, C.-J., Shibata, A., Strauss-Soukup, J. K., Drescher, K. M., et al. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502146 · Cited by 223
Adams, S., Kozhaya, L., Martiniuk, F., Meng, T.-C., Chiriboga, L., Liebes, L., Hochman, T., Shuman, N., Axelrod, D., Speyer, J., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1149 · Cited by 222
Hepatic RIG-I Predicts Survival and Interferon-α Therapeutic Response in Hepatocellular Carcinoma
Hou, J., Zhou, Y., Zheng, Y., Fan, J., Zhou, W., Ng, I. O. L., Sun, H., Qin, L., Qiu, S., Lee, J. M. F., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2013.11.011 · Cited by 221
TLR2 and TLR4 serve distinct roles in the host immune response against Mycobacterium bovis BCG
Heldwein, K. A., Liang, M. D., Andresen, T. K., Thomas, K. E., Marty, A. M., Cuesta, N., Vogel, S. N., & Fenton, M. J. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0103026 · Cited by 221
Zhang, Y.-X., Zhao, Y.-Y., Shen, J., Sun, X., Liu, Y., Liu, H., Wang, Y., & Wang, J. (2019) · Nano Letters · doi:10.1021/acs.nanolett.8b04296 · Cited by 220
Systemic vaccination induces CD8+ T cells and remodels the tumor microenvironment
Baharom, F., Ramirez-Valdez, R. A., Khalilnezhad, A., Khalilnezhad, S., Dillon, M., Hermans, D., Fussell, S., Tobin, K. K. S., Dutertre, C.-A., Lynn, G. M., et al. (2022) · Cell · doi:10.1016/j.cell.2022.10.006 · Cited by 219
Decreased expression of STING predicts poor prognosis in patients with gastric cancer
Song, S., Peng, P., Tang, Z., Zhao, J., Wu, W., Li, H., Shao, M., Li, L., Yang, C., Duan, F., et al. (2017) · Scientific Reports · doi:10.1038/srep39858 · Cited by 216
Ohta, A., Ohta, A., Madasu, M., Kini, R., Subramanian, M., Goel, N., & Sitkovsky, M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901247 · Cited by 215
Mohamed, E., Sierra, R. A., Trillo-Tinoco, J., Cao, Y., Innamarato, P., Payne, K. K., de Mingo Pulido, A., Mandula, J., Zhang, S., Thevenot, P., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.03.004 · Cited by 215
Cai, Z., Sanchez, A., Shi, Z., Zhang, T., Liu, M., & Zhang, D. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-1993 · Cited by 214
NLRC3 is an inhibitory sensor of PI3K–mTOR pathways in cancer
Karki, R., Man, S. M., Malireddi, R. K. S., Kesavardhana, S., Zhu, Q., Burton, A. R., Sharma, B. R., Qi, X., Pelletier, S., Vogel, P., et al. (2016) · Nature · doi:10.1038/nature20597 · Cited by 213
Glycerol phosphate shuttle enzyme GPD2 regulates macrophage inflammatory responses
Langston, P. K., Nambu, A., Jung, J., Shibata, M., Aksoylar, H. I., Lei, J., Xu, P., Doan, M. T., Jiang, H., MacArthur, M. R., et al. (2019) · Nature Immunology · doi:10.1038/s41590-019-0453-7 · Cited by 212
STING-Mediated DNA Sensing Promotes Antitumor and Autoimmune Responses to Dying Cells
Klarquist, J., Hennies, C. M., Lehn, M. A., Reboulet, R. A., Feau, S., & Janssen, E. M. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401869 · Cited by 211
Metabolic Pathways Involved in Regulatory T Cell Functionality
Kempkes, R. W. M., Joosten, I., Koenen, H. J. P. M., & He, X. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02839 · Cited by 211
Kim, Y. H., Gratzinger, D., Harrison, C., Brody, J. D., Czerwinski, D. K., Ai, W. Z., Morales, A., Abdulla, F., Xing, L., Navi, D., et al. (2012) · Blood · doi:10.1182/blood-2011-05-355222 · Cited by 210
Toll-like receptor stimulation in cancer: A pro- and anti-tumor double-edged sword
Dajon, M., Iribarren, K., & Cremer, I. (2017) · Immunobiology · doi:10.1016/j.imbio.2016.06.009 · Cited by 210
Kim, H., Niu, L., Larson, P., Kucaba, T. A., Murphy, K. A., James, B. R., Ferguson, D. M., Griffith, T. S., & Panyam, J. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.02.034 · Cited by 210
Glial and myeloid heterogeneity in the brain tumour microenvironment
Andersen, B. M., Faust Akl, C., Wheeler, M. A., Chiocca, E. A., Reardon, D. A., & Quintana, F. J. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00397-3 · Cited by 208
Neutrophil-activating therapy for the treatment of cancer
Linde, I. L., Prestwood, T. R., Qiu, J., Pilarowski, G., Linde, M. H., Zhang, X., Shen, L., Reticker-Flynn, N. E., Chiu, D. K.-C., Sheu, L. Y., et al. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.01.002 · Cited by 208
Chen, T., Xu, Z.-G., Luo, J., Manne, R. K., Wang, Z., Hsu, C.-C., Pan, B.-S., Cai, Z., Tsai, P.-J., Tsai, Y.-S., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.07.009 · Cited by 208
Self-citationCarpentier, A., Metellus, P., Ursu, R., Zohar, S., Lafitte, F., Barrie, M., Meng, Y., Richard, M., Parizot, C., Laigle-Donadey, F., et al. (2010) · Neuro-Oncology · doi:10.1093/neuonc/nop047 · Cited by 206
CD73 immune checkpoint defines regulatory NK cells within the tumor microenvironment
Neo, S. Y., Yang, Y., Record, J., Ma, R., Chen, X., Chen, Z., Tobin, N. P., Blake, E., Seitz, C., Thomas, R., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci128895 · Cited by 206
Chelvanambi, M., Fecek, R. J., Taylor, J. L., & Storkus, W. J. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001906 · Cited by 201
Long noncoding RNA PANDA and scaffold-attachment-factor SAFA control senescence entry and exit
Puvvula, P. K., Desetty, R. D., Pineau, P., Marchio, A., Moon, A., Dejean, A., & Bischof, O. (2014) · Nature Communications · doi:10.1038/ncomms6323 · Cited by 200
Zhan, Z., Xie, X., Cao, H., Zhou, X., Zhang, X. D., Fan, H., & Liu, Z. (2014) · Autophagy · doi:10.4161/auto.27162 · Cited by 200
Ancey, P.-B., Contat, C., Boivin, G., Sabatino, S., Pascual, J., Zangger, N., Perentes, J. Y., Peters, S., Abel, E. D., Kirsch, D. G., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-2870 · Cited by 199
Antitumor Activity of the TLR-5 Ligand Flagellin in Mouse Models of Cancer
Sfondrini, L., Rossini, A., Besusso, D., Merlo, A., Tagliabue, E., Mènard, S., & Balsari, A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.11.6624 · Cited by 194
Schuurhuis, D. H., Laban, S., Toes, R. E. M., Ricciardi-Castagnoli, P., Kleijmeer, M. J., van der Voort, E. I. H., Rea, D., Offringa, R., Geuze, H. J., Melief, C. J. M., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.1.145 · Cited by 192
Alloatti, A., Kotsias, F., Pauwels, A.-M., Carpier, J.-M., Jouve, M., Timmerman, E., Pace, L., Vargas, P., Maurin, M., Gehrmann, U., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.11.006 · Cited by 189
Akazawa, T., Ebihara, T., Okuno, M., Okuda, Y., Shingai, M., Tsujimura, K., Takahashi, T., Ikawa, M., Okabe, M., Inoue, N., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605978104 · Cited by 188
Yang, Y., Wu, M., Cao, D., Yang, C., Jin, J., Wu, L., Hong, X., Li, W., Lu, L., Li, J., et al. (2021) · Science Advances · doi:10.1126/sciadv.abf6290 · Cited by 187
Aspord, C., Leccia, M.-T., Charles, J., & Plumas, J. (2013) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-13-0114-t · Cited by 187
Dendritic Cell Metabolism and Function in Tumors
Giovanelli, P., Sandoval, T. A., & Cubillos-Ruiz, J. R. (2019) · Trends in Immunology · doi:10.1016/j.it.2019.06.004 · Cited by 187
Inflammatory signaling cascades and autophagy in cancer
Monkkonen, T., & Debnath, J. (2018) · Autophagy · doi:10.1080/15548627.2017.1345412 · Cited by 186
NLRP3 inflammasome-mediated cytokine production and pyroptosis cell death in breast cancer
Faria, S. S., Costantini, S., de Lima, V. C. C., de Andrade, V. P., Rialland, M., Cedric, R., Budillon, A., & Magalhães, K. G. (2021) · Journal of Biomedical Science · doi:10.1186/s12929-021-00724-8 · Cited by 186
Rhee, S. H., Im, E., & Pothoulakis, C. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.04.022 · Cited by 183
Cancer therapies activate RIG-I-like receptor pathway through endogenous non-coding RNAs
Ranoa, D. R. E., Parekh, A. D., Pitroda, S. P., Huang, X., Darga, T., Wong, A. C., Huang, L., Andrade, J., Staley, J. P., Satoh, T., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8420 · Cited by 183
Jian, S.-L., Chen, W.-W., Su, Y.-C., Su, Y.-W., Chuang, T.-H., Hsu, S.-C., & Huang, L.-R. (2017) · Cell Death & Disease · doi:10.1038/cddis.2017.192 · Cited by 183
STING agonist promotes CAR T cell trafficking and persistence in breast cancer
Xu, N., Palmer, D. C., Robeson, A. C., Shou, P., Bommiasamy, H., Laurie, S. J., Willis, C., Dotti, G., Vincent, B. G., Restifo, N. P., et al. (2021) · Journal of Experimental Medicine · doi:10.1084/jem.20200844 · Cited by 181
PD-L1/PD-1 Axis in Glioblastoma Multiforme
Litak, J., Mazurek, M., Grochowski, C., Kamieniak, P., & Roliński, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215347 · Cited by 180
Ribas, A., Medina, T., Kirkwood, J. M., Zakharia, Y., Gonzalez, R., Davar, D., Chmielowski, B., Campbell, K. M., Bao, R., Kelley, H., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0425 · Cited by 180
Berger, G., Knelson, E. H., Jimenez-Macias, J. L., Nowicki, M. O., Han, S., Panagioti, E., Lizotte, P. H., Adu-Berchie, K., Stafford, A., Dimitrakakis, N., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2111003119 · Cited by 179
Duewell, P., Steger, A., Lohr, H., Bourhis, H., Hoelz, H., Kirchleitner, S. V., Stieg, M. R., Grassmann, S., Kobold, S., Siveke, J. T., et al. (2014) · Cell Death & Differentiation · doi:10.1038/cdd.2014.96 · Cited by 179
Diversification of human plasmacytoid predendritic cells in response to a single stimulus
Alculumbre, S. G., Saint‐André, V., Domizio, J. D., Vargas, P., Sirven, P., Bost, P., Maurin, M., Maiuri, P., Wéry, M., Jouve, M. J., et al. (2017) · Nature Immunology · doi:10.1038/s41590-017-0012-z · Cited by 179
Therapeutically Active RIG-I Agonist Induces Immunogenic Tumor Cell Killing in Breast Cancers
Elion, D. L., Jacobson, M. E., Hicks, D. J., Rahman, B., Sanchez, V., Gonzales-Ericsson, P. I., Fedorova, O., Pyle, A. M., Wilson, J. T., & Cook, R. S. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0730 · Cited by 179
Sarhan, J., Liu, B. C., Muendlein, H. I., Weindel, C. G., Smirnova, I., Tang, A. Y., Ilyukha, V., Sorokin, M., Buzdin, A., Fitzgerald, K. A., et al. (2019) · Cell Death & Differentiation · doi:10.1038/s41418-018-0122-7 · Cited by 178
Li, J., Zhao, J., Tan, T., Liu, M., Zeng, Z., Zeng, Y., Zhang, L., Fu, C., Chen, D., & Xie, T. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s243223 · Cited by 178
Hermoso, M. A., Matsuguchi, T., Smoak, K., & Cidlowski, J. A. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.11.4743-4756.2004 · Cited by 176
Cai, H., Yan, L., Liu, N., Xu, M., & Cai, H. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109790 · Cited by 175
STAT3 serine phosphorylation is required for TLR4 metabolic reprogramming and IL-1β expression
Balic, J. J., Albargy, H. A., Luu, K., Kirby, F. J., Jayasekara, W. S. N., Mansell, F., Garama, D. J., Nardo, D. D., Baschuk, N., Louis, C., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17669-5 · Cited by 174
Chemical Strategies to Boost Cancer Vaccines
Li, W.-H., & Li, Y.-M. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.9b00833 · Cited by 173
Luke, J. J., Piha-Paul, S. A., Medina, T., Verschraegen, C. F., Varterasian, M., Brennan, A. M., Riese, R. J., Sokolovska, A., Strauss, J., Hava, D. L., et al. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-0118 · Cited by 173
Poly(I:C) as cancer vaccine adjuvant: Knocking on the door of medical breakthroughs
Ammi, R., De Waele, J., Willemen, Y., Van Brussel, I., Schrijvers, D. M., Lion, E., & Smits, E. L. J. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.09.010 · Cited by 172
van Deventer, H. W., Burgents, J. E., Wu, Q. P., Woodford, R.-M. T., Brickey, W. J., Allen, I. C., McElvania-Tekippe, E., Serody, J. S., & Ting, J. P.-Y. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1921 · Cited by 172
Systemic application of CpG‐rich DNA suppresses adaptive T cell immunity via induction of IDO
Wingender, G., Garbi, N., Schumak, B., Jüngerkes, F., Endl, E., von Bubnoff, D., Steitz, J., Striegler, J., Moldenhauer, G., Tüting, T., et al. (2006) · European Journal of Immunology · doi:10.1002/eji.200535602 · Cited by 170
Dubinski, D., Wölfer, J., Hasselblatt, M., Schneider-Hohendorf, T., Bogdahn, U., Stummer, W., Wiendl, H., & Grauer, O. M. (2016) · Neuro-Oncology · doi:10.1093/neuonc/nov280 · Cited by 169
IL-15–PI3K–AKT–mTOR: A Critical Pathway in the Life Journey of Natural Killer Cells
Ali, A. K., Nandagopal, N., & Lee, S. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00355 · Cited by 168
Miller-Ocuin, J. L., Liang, X., Boone, B. A., Doerfler, W. R., Singhi, A. D., Tang, D., Kang, R., Lotze, M. T., & Zeh, H. J. (2019) · OncoImmunology · doi:10.1080/2162402x.2019.1605822 · Cited by 168
CNS-Native Myeloid Cells Drive Immune Suppression in the Brain Metastatic Niche through Cxcl10
Guldner, I. H., Wang, Q., Yang, L., Golomb, S. M., Zhao, Z., Lopez, J. A., Brunory, A., Howe, E. N., Zhang, Y., Palakurthi, B., et al. (2020) · Cell · doi:10.1016/j.cell.2020.09.064 · Cited by 168
A. Muciniphila Suppresses Colorectal Tumorigenesis by Inducing TLR2/NLRP3-Mediated M1-Like TAMs
Fan, L., Xu, C., Ge, Q., Lin, Y., Wong, C. C., Qi, Y., Ye, B., Lian, Q., Zhuo, W., Si, J., et al. (2021) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-20-1019 · Cited by 168
Ni, K., Luo, T., Culbert, A., Kaufmann, M., Jiang, X., & Lin, W. (2020) · Journal of the American Chemical Society · doi:10.1021/jacs.0c05039 · Cited by 167
Selective STING stimulation in dendritic cells primes antitumor T cell responses
Jneid, B., Bochnakian, A., Hoffmann, C., Delisle, F., Djacoto, E., Sirven, P., Denizeau, J., Sedlik, C., Gerber-Ferder, Y., Fiore, F., et al. (2023) · Science Immunology · doi:10.1126/sciimmunol.abn6612 · Cited by 167
TGF-β Signaling in Myeloid Cells Is Required for Tumor Metastasis
Pang, Y., Gara, S. K., Achyut, B. R., Li, Z., Yan, H. H., Day, C., Weiss, J. M., Trinchieri, G., Morris, J. C., & Li, Y. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0527 · Cited by 166
Chen, D., Le, S. B., Hutchinson, T. E., Calinescu, A.-A., Sebastian, M., Jin, D., Liu, T., Ghiaseddin, A. P., Rahman, M., & Tran, D. D. (2022) · Journal of Clinical Investigation · doi:10.1172/jci149258 · Cited by 166
Gemta, L. F., Siska, P. J., Nelson, M. E., Gao, X., Liu, X., Locasale, J. W., Yagita∥, H., Slingluff, C. L., Hoehn, K. L., Rathmell, J. C., et al. (2019) · Science Immunology · doi:10.1126/sciimmunol.aap9520 · Cited by 165
TGFβ drives NK cell metabolic dysfunction in human metastatic breast cancer
Slattery, K., Woods, E., Zaiatz-Bittencourt, V., Marks, S. J., Chew, S. M., Conroy, M. R., Goggin, C., Eochagáin, C. M., Kennedy, J., Lucas, S., et al. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-002044 · Cited by 165
Manda‐Handzlik, A., & Demkow, U. A. (2019) · Cells · doi:10.3390/cells8121477 · Cited by 164
Zhu, Q., Man, S. M., Gurung, P., Liu, Z., Vogel, P., Lamkanfi, M., & Kanneganti, T. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1402051 · Cited by 163
Toll-like receptor 2 mediates microglia/brain macrophage MT1-MMP expression and glioma expansion
Vinnakota, K., Hu, F., Ku, M., Georgieva, P. B., Szulzewsky, F., Pohlmann, A., Waiczies, S., Waiczies, H., Niendorf, T., Lehnardt, S., et al. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not115 · Cited by 163
Origins, Biology, and Diseases of Tissue Macrophages
Cox, N., Pokrovskii, M., Vicario, R., & Geissmann, F. (2021) · Annual Review of Immunology · doi:10.1146/annurev-immunol-093019-111748 · Cited by 163
The NLRP1 inflammasome attenuates colitis and colitis-associated tumorigenesis
Williams, T. M., Leeth, R. A., Rothschild, D. E., Coutermarsh-Ott, S. L., McDaniel, D. K., Simmons, A. E., Heid, B., Cecere, T. E., & Allen, I. C. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402098 · Cited by 162
MiR-22 sustains NLRP3 expression and attenuates H. pylori-induced gastric carcinogenesis
Li, S., Liang, X., Ma, L., Shen, L., Li, T., Zheng, L., Sun, A., Shang, W., Chen, C., Zhao, W., et al. (2018) · Oncogene · doi:10.1038/onc.2017.381 · Cited by 162
Monte, L. B. D., Wörmann, S. M., Brunetto, E., Heltai, S., Magliacane, G., Reni, M., Paganoni, A. M., Recalde, H. R., Mondino, A., Falconi, M., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-1801-t · Cited by 161
Wu, C., Andzinski, L., Kasnitz, N., Kröger, A., Klawonn, F., Lienenklaus, S., Weiß, S., & Jabłońska, J. (2015) · International Journal of Cancer · doi:10.1002/ijc.29444 · Cited by 159
Liu, G., & Zhao, Y. (2007) · Immunology · doi:10.1111/j.1365-2567.2007.02651.x · Cited by 159
Andaloussi, A. E., Sonabend, A. M., Han, Y., & Lesniak, M. S. (2006) · Glia · doi:10.1002/glia.20401 · Cited by 159
NLRC5 Deficiency Selectively Impairs MHC Class I- Dependent Lymphocyte Killing by Cytotoxic T Cells
Staehli, F., Ludigs, K., Heinz, L. X., Seguín-Estévez, Q., Ferrero, I., Braun, M., Schroder, K., Rebsamen, M., Tardivel, A., Mattmann, C., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102671 · Cited by 158
Tumor-associated antigen-based personalized dendritic cell vaccine in solid tumor patients
Wang, Q.-T., Nie, Y., Sun, S.-N., Lin, T., Han, R.-J., Jiang, J., Li, Z., Li, J.-Q., Xiao, Y.-P., Fan, Y.-Y., et al. (2020) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-020-02496-w · Cited by 158
Pro-inflammatory and proliferative microglia drive progression of glioblastoma
Liu, H., Sun, Y., Zhang, Q., Jin, W., Gordon, R. E., Zhang, Y., Wang, J., Sun, C., Wang, Z., Qi, X., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109718 · Cited by 158
STING is a cell-intrinsic metabolic checkpoint restricting aerobic glycolysis by targeting HK2
Zhang, L., Jiang, C., Zhong, Y., Sun, K., Jing, H., Song, J., Xie, J., Zhou, Y., Tian, M., Zhang, C., et al. (2023) · Nature Cell Biology · doi:10.1038/s41556-023-01185-x · Cited by 158
Ellermeier, J., Wei, J., Duewell, P., Hoves, S., Stieg, M. R., Adunka, T., Noerenberg, D., Anders, H., Mayr, D. C., Poeck, H., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-11-3850 · Cited by 157
Microglia and the Process of Phagocytosis in Gliomas.
Penfield, W. G. (1925) · Europe PMC (PubMed Central) · Cited by 153
STING suppresses bone cancer pain via immune and neuronal modulation
Wang, K., Donnelly, C. R., Jiang, C., Liao, Y., Luo, X., Tao, X., Bang, S., McGinnis, A., Lee, M. S., Hilton, M. J., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24867-2 · Cited by 153
Self-citationWei, Q., Guo, P., Mu, K., Zhang, Y., Zhao, W., Huai, W., Qiu, Y., Li, T., Ma, X., Liu, Y., et al. (2015) · Laboratory Investigation · doi:10.1038/labinvest.2015.63 · Cited by 152
Tumoural activation of TLR3–SLIT2 axis in endothelium drives metastasis
Tavora, B., Mederer, T., Wessel, K. J., Ruffing, S., Sadjadi, M., Missmahl, M., Ostendorf, B. N., Liu, X., Kim, J.-Y., Olsen, O., et al. (2020) · Nature · doi:10.1038/s41586-020-2774-y · Cited by 152
Lauzon, N. M., Mian, F., Mackenzie, R., & Ashkar, A. A. (2006) · Cellular Immunology · doi:10.1016/j.cellimm.2006.08.004 · Cited by 151
MDA5 and LGP2: Accomplices and Antagonists of Antiviral Signal Transduction
Rodriguez, K. R., Bruns, A. M., & Horvath, C. M. (2014) · Journal of Virology · doi:10.1128/jvi.00640-14 · Cited by 150
Rodriguez-Ruiz, M. E., Perez‐Gracia, J. L., Rodríguez, I., Alfaro, C., Oñate, C., Pérez, G., Bazo, I. G., Benito, A., Inogés, S., de Cerio, A. L.-D., et al. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy089 · Cited by 150
cGAS suppresses genomic instability as a decelerator of replication forks
Chen, H., Chen, H., Zhang, J., Wang, Y., Simoneau, A., Yang, H., Levine, A. S., Zou, L., Chen, Z. J., & Lan, L. (2020) · Science Advances · doi:10.1126/sciadv.abb8941 · Cited by 149
Self-citationToll-like receptors and toll-like receptor-targeted immunotherapy against glioma
Xun, Y., Yang, H., Kaminska, B., & You, H. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01191-2 · Cited by 148
Self-citationToll-like receptors expressed in tumor cells: targets for therapy
Yu, L., & Chen, S. (2008) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-008-0459-8 · Cited by 147
Bhatia, S., Miller, N. J., Lu, H., Longino, N. V., Ibrani, D., Shinohara, M. M., Byrd, D. R., Parvathaneni, U., Kulikauskas, R. M., ter Meulen, J., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-0469 · Cited by 146
Liu, Q., Li, C., Fu, L., Wang, H.-L., Tan, J., Wang, Y.-Q., Sun, D., Gao, Q., Chen, Y., & Fang, J. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1788900 · Cited by 146
Control of tumor-associated macrophage responses by nutrient acquisition and metabolism
Zhang, X., Ji, L., & Li, M. O. (2023) · Immunity · doi:10.1016/j.immuni.2022.12.003 · Cited by 146
Zhang, Y., Luo, F., Cai, Y., Liu, N., Wang, L., Xu, D., & Chu, Y. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002320 · Cited by 145
NLRP3 promotes tumor growth and metastasis in human oral squamous cell carcinoma
Wang, H., Luo, Q., Feng, X., Zhang, R., Li, J., & Chen, F. (2018) · BMC Cancer · doi:10.1186/s12885-018-4403-9 · Cited by 145
Yao, R., Li, J., Zhang, R., Chen, R., & Wang, Y. (2018) · World Journal of Surgical Oncology · doi:10.1186/s12957-018-1312-y · Cited by 144
Li, Z., Zhang, Y., Hong, W., Wang, B., Chen, Y., Yang, P., Zhou, J., Fan, J., Zeng, Z., & Du, S. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2119055 · Cited by 142
A cell-intrinsic role for TLR2–MYD88 in intestinal and breast epithelia and oncogenesis
Scheeren, F. A., Kuo, A. H., van Weele, L. J., Cai, S., Glykofridis, I. E., Sikandar, S. S., Zabala, M., Qian, D., Lam, J. S., Johnston, D. M., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb3058 · Cited by 141
RIG-I activation is critical for responsiveness to checkpoint blockade
Heidegger, S. M., Wintges, A., Stritzke, F., Bek, S., Steiger, K., Koenig, P.-A., Göttert, S., Engleitner, T., Öllinger, R., Nedelko, T., et al. (2019) · Science Immunology · doi:10.1126/sciimmunol.aau8943 · Cited by 141
Gong, Z., Li, Q., Shi, J., Liu, E. T., Shultz, L. D., & Ren, G. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.11.003 · Cited by 140
Mannan-Modified Solid Lipid Nanoparticles for Targeted Gene Delivery to Alveolar Macrophages
Yu, W., Liu, C., Liu, Y., Zhang, N., & Xu, W. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0149-z · Cited by 137
Glioblastoma hijacks microglial gene expression to support tumor growth
Maas, S. L. N., Abels, E. R., van de Haar, L. L., Zhang, X., Morsett, L. M., Sil, S., Guedes, J. R., Sen, P., Prabhakar, S., Hickman, S. E., et al. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01797-2 · Cited by 137
Wang, Y., Liu, F., Chen, L., Chen, F., Li, S., Yuan, S., Qian, X., Yin, Y., Yu, B., Fu, B., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.867516 · Cited by 137
Wang, M., Cai, Y., Peng, Y., Xu, B., Hui, W., & Jiang, Y. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-03042-3 · Cited by 136
Fucikova, J., Truxova, I., Hensler, M., Becht, E., Kasikova, L., Moserova, I., Vosahlikova, S., Klouckova, J., Church, S. E., Cremer, I., et al. (2016) · Blood · doi:10.1182/blood-2016-08-731737 · Cited by 135
Liu, J., Xiang, J., Jin, C., Ye, L., Wang, L., Gao, Y., Lv, N., Zhang, J., You, F., Qiao, H., et al. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01835-0 · Cited by 132
Cited by
Huynh, T. M. H., Huang, P.-X., Wang, K.-L., Tran, N.-T., Iao, H. M., Pan, W.-C., Chang, Y.-H., Lien, H.-W., Lee, A. Y.-L., Chou, T.-C., et al. (2025) · ACS Nano · doi:10.1021/acsnano.5c05395 · Cited by 122
Neutrophils and Neutrophil-Based Drug Delivery Systems in Anti-Cancer Therapy
Wahnou, H., El Kebbaj, R., Hba, S., Ouadghiri, Z., El Faqer, O., Pinon, A., Liagre, B., Limami, Y., & Duval, R. E. (2025) · Cancers · doi:10.3390/cancers17071232 · Cited by 35
Immunogenic cell death mediated TLR3/4-activated MSCs in U87 GBM cell line
Emami Meybodi, S. M., Moradi Moraddahande, F., & Dehghani Firoozabadi, A. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e29858 · Cited by 3
Metadata
- Authors
- Hu, A., Sun, L., Lin, H., Liao, Y., Yang, H., & Mao, Y.
- Venue
- Signal Transduction and Targeted Therapy
- Published
- 2024-03-25
- Volume
- 9
- Issue
- 1
- Pages
- 68-68
- ISSN
- 2059-3635 (ISSN-L)
- OpenAlex
- W4394738965
- Cited by
- 255
- References
- 670
- FWCI
- 38.98
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.